Overview

* Insperity ( NSP ) Q2 revenue rises 3% yr/yr but missed analyst expectations

* Adjusted EPS for Q2 misses consensus, reflecting higher benefits costs

* Co reports Q2 net loss of $5 mln, adjusted EBITDA misses estimates

Outlook

* Insperity ( NSP ) sees Q3 adjusted EPS between $0.06 and $0.49

* Company expects full-year adjusted EPS of $1.81 to $2.51

* Insperity ( NSP ) forecasts Q3 adjusted EBITDA of $24 mln to $44 mln

* Company projects full-year adjusted EBITDA of $170 mln to $205 mln

Result Drivers

* HIGHER HEALTHCARE COSTS - Gross profit decline attributed to elevated healthcare costs, including pharmacy trends and large claim activity

* REVENUE GROWTH - 3% revenue increase driven by higher pricing and slight increase in average paid WSEEs

* BENEFIT PLAN CHANGES - Co implementing benefit plan design changes to address elevated benefits cost trend, per CFO James D. Allison

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Miss $1.66 $1.66

Revenue bln bln (5

Analysts

)

Q2 Miss $0.26 $0.43 (5

Adjusted Analysts

EPS )

Q2 Net -$5 mln

Income

Q2 Miss $32 mln $39.80

Adjusted mln (5

EBITDA Analysts

)

Q2 Miss -$7 mln $16.20

Operatin mln (3

g income Analysts

)

Q2 Gross $223 mln

Profit

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)